Passage Bio Inc. (PASG): Price and Financial Metrics

Passage Bio Inc. (PASG): $0.51

0.03 (+6.58%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add PASG to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#77 of 331

in industry

PASG Price/Volume Stats

Current price $0.51 52-week high $1.79
Prev. close $0.48 52-week low $0.45
Day low $0.46 Volume 337,500
Day high $0.55 Avg. volume 264,922
50-day MA $0.63 Dividend yield N/A
200-day MA $1.00 Market Cap 31.73M

PASG Stock Price Chart Interactive Chart >


Passage Bio Inc. (PASG) Company Bio


Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company assembles a portfolio of genetic medicine products, which includes PBGM01 for the treatment of GM1, PBFT02 for the treatment of FTD and PBKR03 for the treatment of Krabbe disease. Passage Bio was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.


PASG Latest News Stream


Event/Time News Detail
Loading, please wait...

PASG Latest Social Stream


Loading social stream, please wait...

View Full PASG Social Stream

PASG Price Returns

1-mo -13.71%
3-mo -32.25%
6-mo -54.87%
1-year -16.80%
3-year -93.38%
5-year N/A
YTD -49.50%
2023 -26.81%
2022 -78.27%
2021 -75.17%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!